The erythropoietin‐derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia

BACKGROUND: Cancer cachexia (CC) is a severe complication during the last stages of the disease, which is characterized by the substantial loss of muscle and fat mass. Currently, there is no effective treatment of CC. Erythropoietin plays tissue‐protective role in different tissues. Based on the str...

Descripción completa

Detalles Bibliográficos
Autores principales: Palus, Sandra, Elkina, Yulia, Braun, Tanja, von Haehling, Stephan, Döhner, Wolfram, Anker, Stefan D., Cerami, Anthony, Brines, Michael, Springer, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397558/
https://www.ncbi.nlm.nih.gov/pubmed/35586884
http://dx.doi.org/10.1002/jcsm.13009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397558/
https://www.ncbi.nlm.nih.gov/pubmed/35586884
http://dx.doi.org/10.1002/jcsm.13009

Ejemplares similares